Hepatic stellate cells have received considerable attention as key componen
ts of the fibrogenic response to injury Beyond this feature, they also have
been implicated as regulators of sinusoidal vascular tone, and in disease
states, in the pathogenesis of intrahepatic portal hypertension. The basis
for this latter concept is derived from the following: (a) stellate cells a
re situated in a perisinusoidal orientation within the sinusoid, optimized
for sinusoidal constriction; (b) a series of studies performed-over the pas
t decade have demonstrated that perisinusoidal stellate cells exhibit a rem
arkable capacity for cellular contraction, a characteristic that is most pr
ominent after liver injury and stellate cell activation; and (c) in vivo mi
croscopy studies have revealed that stellate cells can mediate sinusoidal c
onstriction. Available evidence indicates that liver injury leads to a vasc
ular disorder in which endothelin-1 is overproduced by stellate cells and e
ndothelial cell-derived nitric oxide production is reduced. These abnormali
ties, in the context of exaggerated stellate cell contractility after liver
injury, set up a paradigm in which stellate cells contribute to the increa
sed intrahepatic resistance typical of portal hypertension. Furthermore, be
cause stellate cell contractility and the mediators that control this funct
ion are dynamic processes, strategies that target exaggerated contractility
provide an opportunity for novel therapeutics in intrahepatic portal hyper
tension.